Pre-existing depression confers increased risk for both long-term mortality and major adverse cardiovascular events after coronary artery bypass grafting.
Central Message
In patients undergoing coronary artery bypass grafting, pre-existing depression was significantly associated with increased risk for both long-term mortality and major adverse cardiovascular events.
Perspective
Depressed patients undergoing coronary artery bypass grafting experience worse clinical outcomes. However, data are limited in this patient population. Existing evidence suggests that pre-existing depression is associated with morbidity and mortality in patients who undergo coronary artery bypass grafting. Whether pre-existing depression truly influences clinical outcomes postoperatively remains unresolved.
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survival. The search accounted for plurals and variations in spelling with the use of appropriate wildcards. To identify further articles, we hand-searched related citations in review articles and commentaries. Published abstracts or unpublished data were not included because reports indicate discrepancies between published and unpublished data. 15, 16 All results were downloaded into EndNote (Clarivate Analytics, Philadelphia, Pa) and duplicate citations were identified and removed.
Study Selection
The eligibility of studies was assessed by 2 investigators (T.W. and L.B.F.) independent of each other. Included studies were those that compared clinical outcomes in patients with or without depression who underwent myocardial revascularization with CABG. There was no restriction of study design, language, or number of participants. In the case of >1 study from the same population, we included the study that had more number of patients or a longer follow-up period. Studies were excluded if they reported outcomes from the same patient population, reported no clinical outcomes, or reported outcomes other than those relevant to our analysis.
Data Extraction
Two reviewers (L.B.F. and A.C.) extracted data from the included studies independently from each other. The data were extracted into a predefined spreadsheet that included details about the study characteristics, setting (in-hospital or general population), study design, patient characteristics, details of the surgical procedure, and relevant outcomes. Because the modality for diagnosing depression differed amongst the included studies, the diagnosis of depression was accepted in our analysis as reported by the individual studies. The relevant outcomes measured in our analysis were all-cause mortality or a combined end point of cardiac mortality and morbidity in patients with depression who underwent CABG. The definition of morbidity varied in the included studies but included angina, myocardial infarction, stroke, rehospitalization, infection, or a repeat procedure in almost all of the studies. There was no a priori definition of the time of assessment of mortality or morbidity and definitions were accepted as reported in the included studies. Long-term mortality was considered after 12 months because early outcomes may be influenced by the associated surgical risk.
Data Synthesis and Statistical Analysis
Continuous data were reported either as mean AE standard deviation or median (interquartile range). The primary effect measure included in our analysis was hazard ratio (HR), as reported in the studies. One study reported adjusted odds ratio (OR), which was used to calculate relative risk because both measures of association are known to approximate each other when the incidence of events in the control population are low. Both relative risk and HR were assumed to evaluate the same association and were pooled together. The relevant outcomes in our analysis were pooled with only adjusted effect estimates by the generic inverse variance method using a random-effects model based on the associated heterogeneity encountered. The I 2 statistic was used to assess heterogeneity among studies. 17 Publication bias was not assessed because of a limited number of studies. Unadjusted effect estimates were not included in our analysis to decrease bias. Sensitivity analysis was done to investigate the robustness of the effect estimate by 1-study removal analysis. Subgroup analysis was done to evaluate any difference in outcomes based on the assessment or definition of depression (objective assessment by questionnaires compared with diagnosis from administrative, pharmacy, or hospital databases).
Quality Assessment
Two reviewers (L.B.F. and A.R.K.) independently assessed the methodologic quality of the selected studies using the NewcastleOttawa Scale. This scale involves evaluation of observational studies based on 3 areas: selection of the study groups, comparability among groups, and the assessment of outcome among the groups. 18 The scale assigns a maximum of 4 points for selection, 2 points for comparability, and 3 points for exposure/outcome assessment. Studies with >7 points were considered high quality and studies with <5 points were considered low quality. Any disagreements between reviewers in study inclusion, data extraction, and quality assessment were resolved by consensus. All analyses were conducted using the statistical software Review Manager version 5.2 (Cochrane Community, London, United Kingdom). Our systematic review was carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Metaanalyses and meta-analysis of observational studies in epidemiology guidelines. 19, 20 
RESULTS
The literature search identified 1388 publications, out of which 10 studies were eligible for our analysis 14, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ( Figure 1 ). Connerney and colleagues 21 reported cardiac morbidity at 1 year and mortality at 10 years 22 in 2 different studies, both of which were included in our analysis. Included studies were observational, with data extracted either from in-patient hospital records or administrative and pharmacy databases. Studies reported outcomes in a cohort of patients with depression and reported adjusted outcomes in all studies except 2, which reported unadjusted outcomes. Blumenthal and colleagues 23 reported outcomes for both major and minor depression separately, which were combined for our analysis. Two studies reported unadjusted outcomes and were not included in our analysis outcomes. 9, 31 All of the observational studies had good methodologic quality, as assessed by the NewcastleOttawa Scale with a score ! 7. Table 1 summarizes the characteristics of the included studies. Table 2 highlights the characteristics of the patient populations in these studies. A total of 10 studies comprising 152,491 participants (ranging from 119 to 62,656 in individual studies), the largest population studied to date, were included in the analysis. The included studies were conducted in the United States, Australia, and Sweden. The patients included in the studies were predominantly men with a mean age of approximately 61 years. Reported associated comorbidities and other confounders were adjusted for the multivariate analysis or were propensity matched for the analysis (Table E1 ). The prevalence of depression was 13.6% (20,673 out of 152,491) before surgery. The diagnosis and severity of depression was evaluated in the studies either by questionnaires or by the administrative databases. There were different questionnaires used to assess depression: the Depression Anxiety Stress Scale was used in 1 study, 26 Center for Epidemiological Studies-Depression in 1 study, 23 Beck's Depression Inventory in 2 studies, 14, 22 and by the Diagnostic Interview Schedule in 1 study. 22 In the administrative databases, depression was coded per the guidelines from International Classification of Diseases code (9th and 10th revisions) 27, 29, 30 or by the use of antidepressants 28 ( Tables 2 and 3 ). All patients included in the analysis underwent CABG; either isolated CABG or with concomitant valve surgery.
All-Cause Mortality
All the studies provided outcomes for all-cause mortality in patients with depression who underwent CABG. All studies reported mortality beyond 6 months except 1 study, 27 in which in-hospital mortality was evaluated. Nine studies reported time-to-event outcomes as HR, and 1 study reported adjusted OR.
Our meta-analysis definitively showed an increased risk of mortality associated with moderate heterogeneity (HR, 1.42; 95% confidence interval [CI], 1.26-1.60; P < .00001; I 2 ¼ 37%) in patients with depression who underwent CABG (Figure 2 ). Moreover, there was little variability in the pooled results, with 1-study removal analysis further suggesting the robustness of the results (HR, 1.35-1.46; 95% CI, 1.21-1.29 to 1.51-1.68). Also, removal of the study that reported adjusted OR did not change the effect estimate (OR, 1.46; 95% CI, 1.27-1.68; P < .00001). There was little difference in mortality risk based on the diagnostic modality used to assess depression; that is, questionnaire-based method (HR, 1.63; 95% CI, NOS, Newcastle Ottawa Scale; CABG, coronary artery bypass grafting; MI, myocardial infarction: HF, heart failure; NR, not reported; SSRI, selective serotonin reuptake inhibitor; SNRI, serotonin norepinephrine reuptake inhibitor; SWEDEHEART, Swedish Web system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies.
1.13-2.35; P < .01; I 2 ¼ 44%) compared with administrative record review method (HR, 1.39; 95% CI, 1.21-1.61; P < .00001; I 2 ¼ 51%) (Figure 3 ). However, depression diagnosed using a questionnaire-based assessment was associated with a greater (24%) risk for long-term mortality.
Composite End Point: Cardiac Mortality and Morbidity
Six studies reported the association of depression on a composite end point of cardiac mortality and morbidity. 14, 21, 24, 25, 28, 29 As mentioned, there was minor variability in the definition of morbidity in the studies; however, the vast majority included angina, myocardial infarction, stroke, heart failure, arrhythmia, and rehospitalization. All studies reported outcomes adjusted for multiple variables save 1 study, 24 in which the only adjustment was for the cardiopulmonary bypass time.
Our analysis revealed an increased risk for cardiac mortality and morbidity associated with depression (HR, 1.57; 95% CI, 1.39-1.77; P <.00001) (Figure 4 ) with mild heterogeneity (I 2 ¼ 12%; P ¼ .34). Investigation of the heterogeneity showed all the heterogeneity was due to the study by Oxlad and colleagues, 24 who adjusted the outcome for only 1 variable. Removal of the study did not change either the size or direction of the pooled effect estimate, which suggested an increased risk of cardiac mortality and morbidity associated with depression (HR, 1.55; 95% CI, 1.40-1.71; I 2 ¼ 0%).
DISCUSSION
This meta-analysis of patients with pre-existing depression who underwent CABG is the largest cohort studied to date and the most comprehensive study of its kind. Here, we report the following salient findings: we definitely established an association between pre-existing psychological depression and decreased long-term survival; our meta-analysis demonstrates that when additional relevant cardiac outcomes, including, specifically, cardiac mortality, and cardiac morbidity (as part of a combined clinical end point to include major adverse clinical events and rehospitalization), are considered, the negative association between depression and mortality persists; and the risk of mortality was not significantly influenced by the modality used to diagnose depression in the cohort.
Data from a very recent meta-analysis suggested an association between depression and decreased long-term survival following CABG. 7 However, that study failed to evaluate the effect of depression on cardiac morbidity. By analyzing the association between depression and all-cause mortality only, the true influence of depression on cardiac-related events may have been underestimated. 7 We found that, apart from decreased survival following CABG, pre-existing depression was significantly associated with an increase in our composite end point of major adverse cardiovascular events, including hospital readmission. These data provide a more complete analysis of the overall effect of pre-existing depression on long-term survival and cardiac-related events after surgical revascularization. Previous meta-analyses reported an increased risk of mortality in depressed patients with stable CAD or following myocardial infarction. Our analysis not only confirms these findings, but also demonstrates that the risk persists despite revascularization.
Moreover, given the variability in the definition of exposure between studies, subgroup analysis was undertaken here to determine whether the definition of depression altered the observed inverse relationship with all-cause mortality. Regardless of how depression was defined in our study, either by questionnaire or administrative records, the increase in mortality associated with depression persisted. However, the effect was 24% greater when questionnaires were used to define depression. Conversely, Stenman and colleagues, 7 in their recent meta-analysis of a smaller cohort, found that no association between long-term survival and depression existed when depression was defined by questionnaires. Yet, when antidepressant use was used as a proxy for depression, these investigators observed a significant increase in mortality. Moreover, the variability in the modality used to define depression in our study may have influenced the magnitude of the association but not the direction, suggesting an increased risk of adverse outcomes in all patients with depression.
Our data confirm the findings of numerous individual reports that demonstrate a significant association between pre-existing depression and increased risk of developing neurovascular and cardiovascular comorbidities (eg, angina, myocardial infarction, and stroke), including readmission, particularly during long-term follow-up from CABG. Pathophysiologic explanations for the increased risk of adverse clinical outcomes attributable to psychological depression following CABG remains multifactorial. Historically, psychological depression is also strongly associated with an increased prevalence of traditional cardiovascular risk factors (eg, diabetes, dyslipidemia, systemic hypertension, smoking, sedentary lifestyles, and obesity), which suggests a potential bidirectional pathophysiologic mechanism linking the 2. 13 In addition, novel mechanistic insight from recent studies suggests a causal relationship between psychological depression and autonomic and immune system dysregulation 32,33 instigating a proinflammatory systemic condition. 34 When considered collectively with previous reports, our data reinforce that pre-existing psychological depression is not only a prognosticator for increased cardiac morbidity and mortality following CABG, but also may predict the development and progression of CAD, which ostensibly is the most likely contributor to morbidity and long-term mortality in this cohort.
Limitations
There are several limitations to our analysis. First, the analysis is based on observational studies, leading to limitations due to the inherent design of the studies. Consequently, our results only suggest associations and cannot prove any causal association between depression and adverse outcomes after CABG. Second, studies may have been limited by confounding by both known confounders like concomitant valve surgery but also unknown confounders despite the adjustment made in the studies themselves. Third, a small number of female patients were included in the individual studies analyzed. That the effect of depression and heart disease is more complex in women means that any generalizations made here must be interpreted carefully in this context. 35, 36 Fourth, in a number of the studies analyzed, the diagnosis of depression was made before CABG with no follow-up assessment regarding temporal changes in diagnosis or severity of depression. Fifth, there was variability in the time to follow-up and assessment of morbidity and mortality that may have contributed to the heterogeneity encountered in our results. However, this heterogeneity will affect the magnitude of the association rather than the direction, which suggests an increased risk in all the studies. Sixth, we could not assess for publication bias because of the limited number of studies in our analysis. Finally, our underlying hypothesis was that pre-existing depression could have worse outcomes even in patients who undergo complete revascularization. An alternative inference would be that the magnitude of underlying coronary disease could affect both the severity of depressive symptoms and outcomes after surgery. However, the included studies adjusted for known covariates that may have affected the measured outcomes. As mentioned, to adjust both for known and unknown confounders will require individual patient level-data or can only be tested in a randomized controlled trial.
Implications for Clinical Practice
In addition to advancing our understanding of cardiac surgery and psychology, our results could potentially influence current clinical practices perhaps by placing a greater emphasis on the role of clinical psychologists/ psychiatrists in the preoperative assessment of patients undergoing cardiac surgery. This interdisciplinary approach could be realized in the form of more on-staff clinical psychologists in hospital settings and depression screening and postdischarge follow-up administered in a protocol-based manner. Implementing this paradigm would require more controlled studies to investigate the effect of the intervention on our measured outcomes.
Implications for Research
Data are lacking with regard to the relationship between depression severity and/or subtypes and the measured outcomes. The vast majority of the studies here were pooled together to include mild, moderate, and severe depression. Blumenthal and colleagues 23 and others 37 reported a higher risk of mortality depending on the severity of depression. Thus, whether depression severity influences clinical outcomes remains a matter of great debate.
CONCLUSIONS
Our analysis definitely demonstrates that pre-existing psychological depression is significantly associated with an increased risk for both all-cause mortality and major adverse cardiovascular events. These data are valuable for generating hypotheses and warrant future randomized trials to confirm our findings and to further investigate the effect of intervention on clinical outcomes in this particular cohort.
Conflict of Interest Statement
Authors have nothing to disclose with regard to commercial support. There may have been more than the enumerated comorbidities in the studies, but only those for which adjustment performed are included. LVEF, Left ventricular ejection fraction; NYHA, New York Heart Association; DM, diabetes; HTN, hypertension; HPL, hyperlipidemia; PVD, peripheral vascular disease; CVD, cerebrovascular disease; MI, myocardial infarction; CHF, congestive heart failure; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention; CCS, Canadian Cardiovascular Society class; AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus; OPCAB, Off-pump coronary artery bypass; COPD, chronic obstructive pulmonary disease.
